Trials that use: Multiple imputation / missing data
New to this method? Read the tutorial →
9,924 results
- EFFORTIndependent statistical analysis of Emergency Department (ED) Flow-directed Fluid Optimization Resuscitation Trial (EFFORT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01128413).
- EFforT-BCRLIndependent statistical analysis of Effectiveness of Fluoroscopy-guided MLD for Treatment of BCRL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02609724).
- Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin: Complete Statistical AnalysisIndependent statistical analysis of Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00601640).
- EGFRIndependent statistical analysis of TIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR-mutant/Metastatic NSCLC Who Have Not Had Any Previous EGFR Directed Therapy: primary endpoint results, effect…
- EGGSOTIIndependent statistical analysis of Time-limited Specific Oral Tolerance Induction in Children With Severe Egg Allergy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EGM Analysis in Idiopathic Outflow Tract Ventricular Arrhythmia: Complete Statistical AnalysisIndependent statistical analysis of EGM Analysis in Idiopathic Outflow Tract Ventricular Arrhythmia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02722577).
- eHealth Evidence-based Intervention (EBI) for Latino Youth in Primary Care: Complete Statistical AnalysisIndependent statistical analysis of eHealth Evidence-based Intervention (EBI) for Latino Youth in Primary Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03009539).
- EHPOCIndependent statistical analysis of Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04793750).
- EHR-WWCIndependent statistical analysis of EHR Embedded Comparative Effectiveness Studies--WWC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04514679).
- eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients: Complete Statistical AnalysisIndependent statistical analysis of eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Elafibranor, PK and Safety in Children and Adolescents 8 to 17 Years of Age With Non Alcoholic Steatohepatitis (NASH): Complete Statistical AnalysisIndependent statistical analysis of Elafibranor, PK and Safety in Children and Adolescents 8 to 17 Years of Age With Non Alcoholic Steatohepatitis (NASH): primary endpoint results, effect estimate with confidence interval, sample-size…
- ELARAIndependent statistical analysis of Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ElbowHOIndependent statistical analysis of Radiation Therapy for Heterotopic Ossification Prophylaxis Acutely After Elbow Trauma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00991887).
- ElderTree Via a Voice Activated Device for Managing Chronic Health Conditions (NHLBI): Complete Statistical AnalysisIndependent statistical analysis of ElderTree Via a Voice Activated Device for Managing Chronic Health Conditions (NHLBI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Electric Muscle Stimulation for Patients With Chronic Respiratory Failure: Complete Statistical AnalysisIndependent statistical analysis of Electric Muscle Stimulation for Patients With Chronic Respiratory Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01930643).
- Electrical Muscle Stimulation Versus Resistive Training On Physical Measures, And Fatigue In Hemodialysis Patients: Complete Statistical AnalysisIndependent statistical analysis of Electrical Muscle Stimulation Versus Resistive Training On Physical Measures, And Fatigue In Hemodialysis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Electrical Stimulation and Eccentric Exercise for Anterior Cruciate Ligament (ACL) Injury: Complete Statistical AnalysisIndependent statistical analysis of Electrical Stimulation and Eccentric Exercise for Anterior Cruciate Ligament (ACL) Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Electrical Stimulation for the Treatment of Back Pain Using Peripheral Nerve Stimulation (PNS): Complete Statistical AnalysisIndependent statistical analysis of Electrical Stimulation for the Treatment of Back Pain Using Peripheral Nerve Stimulation (PNS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Electronic Patient-Reported Outcomes in Clinical Kidney Practice (ePRO Kidney): Complete Statistical AnalysisIndependent statistical analysis of Electronic Patient-Reported Outcomes in Clinical Kidney Practice (ePRO Kidney): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03149328).
- ElevageIndependent statistical analysis of Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ELEVATEIndependent statistical analysis of DC Migration Study for Newly-Diagnosed GBM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02366728).
- ELEVATEIndependent statistical analysis of Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures: primary endpoint results, effect estimate with confidence interval,…
- ELEVATE TNBCIndependent statistical analysis of Study of Magrolimab Combination Therapy in Patients With Non-Surgically Removable Locally Advanced or Metastatic Triple-Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ELPISIndependent statistical analysis of Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy: primary endpoint results, effect estimate with…
- Eltrombopag for Fanconi Anemia: Complete Statistical AnalysisIndependent statistical analysis of Eltrombopag for Fanconi Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03206086).
- Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy: Complete Statistical AnalysisIndependent statistical analysis of Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Eltrombopag Phase III Study In Chinese Chronic ITP Patients: Complete Statistical AnalysisIndependent statistical analysis of Eltrombopag Phase III Study In Chinese Chronic ITP Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01762761).
- Elucidation of Acid-Induced Pulmonary Inflammation: Complete Statistical AnalysisIndependent statistical analysis of Elucidation of Acid-Induced Pulmonary Inflammation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00361972).
- Email Campaign to Increase Uptake of myGeisinger: Complete Statistical AnalysisIndependent statistical analysis of Email Campaign to Increase Uptake of myGeisinger: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04332614).
- EMAPIndependent statistical analysis of Esophageal Manometry During Recovery From Anesthesia: Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02661386).
- EMBARCIndependent statistical analysis of Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- EMBODY2Independent statistical analysis of Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Embozene Microspheres for Uterine Fibroid Embolization (UFE): Complete Statistical AnalysisIndependent statistical analysis of Embozene Microspheres for Uterine Fibroid Embolization (UFE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01675011).
- EMBRACEIndependent statistical analysis of Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04252742).
- EmCyteIndependent statistical analysis of Bone Marrow Aspirate Compared to Platelet Rich Plasma for Treating Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Emdogain Minimally Invasive Surgical Technique: Complete Statistical AnalysisIndependent statistical analysis of Emdogain Minimally Invasive Surgical Technique: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02551770).
- EMERALDIndependent statistical analysis of Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE: primary endpoint results, effect estimate with confidence interval,…
- EMERALD-2Independent statistical analysis of A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- EMERGEIndependent statistical analysis of Microenterprise Intervention to Reduce Sexual Risk Behaviors in Young Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03766165).
- Emergence Agitation Between Dexmedetomidine and Sevoflurane Anesthesia: Complete Statistical AnalysisIndependent statistical analysis of Emergence Agitation Between Dexmedetomidine and Sevoflurane Anesthesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06482125).
- Emervel Classic Lidocaine Versus Juvederm® Ultra in Treatment of Moderate to Severe Facial Wrinkles and Folds: Complete Statistical AnalysisIndependent statistical analysis of Emervel Classic Lidocaine Versus Juvederm® Ultra in Treatment of Moderate to Severe Facial Wrinkles and Folds: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Emervel® Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds: Complete Statistical AnalysisIndependent statistical analysis of Emervel® Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- EmiandMeIndependent statistical analysis of An Exploration of the Impact of Emicizumab on the Lives of People With Haemophilia and Inhibitors and Their Families: primary endpoint results, effect estimate with confidence interval, sample-size…
- EMMAIndependent statistical analysis of Extracellular Matrix Marker of Arrhythmia Risk (EMMA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00376532).
- EMMYIndependent statistical analysis of Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- EMMYIndependent statistical analysis of Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Emotion Regulation Interventions for Alcohol-Related Sexual Aggression: Complete Statistical AnalysisIndependent statistical analysis of Emotion Regulation Interventions for Alcohol-Related Sexual Aggression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03159468).
- Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3): Complete Statistical AnalysisIndependent statistical analysis of Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved): Complete Statistical AnalysisIndependent statistical analysis of EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…